The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations

Conditions:   COVID;   Vitamin D Deficiency;   Coagulopathy;   Disseminated Intravascular Coagulation Interventions:   Drug: Aspirin 81 mg;   Dietary Supplement: Vitamin D Sponsor:   Louisiana State University Health Sciences Center in New Orleans Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials